People and science are a beautiful combination.
Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer.
Learn how cancer biology is guiding the study of potential, new combination medicines to treat specific types of cancer.
Producing differentiated small molecules and antibodies designed to optimize combinability
Guided by specific biologic mechanisms of cancer, to advance combination therapies from Phase 1 studies through commercialization
To facilitate participation in our global clinical trials and bring new medicines to patients faster